GENE ONLINE|News &
Opinion
Blog

Small Molecule Drug
BIO 2024 Showcases the Emergence of Taiwan’s Biotech CDMO Market
2024-06-04
Scientists Identified Potential New Drugs to Combat Blindness
2023-05-21
Alectos Promised $722 Million in Parkinson’s Collab With Biogen
2022-06-07
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Denali Taps PharmEnable to Discover AI-Based Small Molecule Candidates for Neurological Diseases
2022-05-30
Refining Psychedelics into Medicine – An Interview with Doug Drysdale, CEO of Cybin
2022-04-19
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
ShouTi Raises $100M in Series B to “Replace Biologic Injections with Pills”
2021-10-21
Expanding Deals and Investments Underscore Burgeoning Market of Targeted Protein Degradation
2021-10-07
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
EU Commission Grants Marketing Authorization for Gilead’s Rheumatoid Arthritis Treatment
2020-10-04
Eisai Obtains Novel Anti-Cancer Molecules via PRISM BioLab Contract
2020-04-13
LATEST
Donald Trump’s “Most Favored Nation” Executive Order on Drug Pricing
2025-05-12
Discover Investment Opportunities & Innovation at International Healthcare Week in Hong Kong from May
2025-05-12
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
President to Sign Executive Order on Trade Enforcement Monday Morning
2025-05-11
Trump to Sign Executive Order Linking U.S. Drug Prices to International Levels.
2025-05-11
Podcast Highlights Agile Biopharmaceutical Firms’ Strategies for Navigating Complex Clinical Trials
2025-05-11
New Mask Detects Chronic Kidney Disease in 84% of Tested Cases
2025-05-11
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top